Plus   Neg

Vodafone In Deal To Offer OPPO Products To European Markets - Quick Facts

Vodafone Group Plc (VOD.L,VOD) announced Monday a comprehensive partnership agreement with China's smartphone maker OPPO. Under the deal, Vodafone will offer a broad range of OPPO's smartphones to its European customers starting from May 2020.

Vodafone said that OPPO, with advanced 5G technology know-how and annual handset shipments of more than 100 million, is a natural partner for its gigabit network. The collaboration is expected to give Vodafone consumers more choice and accelerate 5G adoption across its international markets.

OPPO's products including 5G flagship smartphones such as the OPPO A series, Reno series and Find X series will be made available across Vodafone's retail and online channels.

In the first phase of cooperation, Vodafone will introduce OPPO products across retail channels in Germany, United Kingdom, Spain, Portugal, Romania, Turkey and the Netherlands.

OPPO's most of the manufacturing facilities have resumed normal operation amid Coronavirus outbreak. It is expected that even during the crisis, OPPO can continue to provide products to Vodafone and ensure business continuity.

While physical retail is currently constrained, both companies will develop online sales channels.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hyundai Motor has launched a new IONIQ brand dedicated to battery electric vehicles, as the automaker is accelerating its efforts to gain a share in the fast-growing global EV market. Under the IONIQ brand, Hyundai plans to introduce three new dedicated electric vehicle models over the next four years. Hyundai is South Korea's largest automaker. Amazon.com, Inc. is in talks with mall operator Simon Property Group, Inc. to use the abandoned anchor departmental stores of JC Penny and Sears at their malls as fulfillment centers, reports said. This is expected to help the e-commerce giant in boosting their last mile delivery, which is the last leg of the delivery process. The U.S. Food and Drug Administration announced the approval of Trevena Inc.'s Olinvyk (oliceridine), a new opioid for intravenous use in hospitals or other controlled clinical settings. Olinvyk is an opioid agonist to manage moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Follow RTT